NCKCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。NCK遺伝子サイレンサーは、NCK CRISPR/Cas9ノックアウトプラスミドとNCKDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のNCKCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
NCK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
NCK1 CRISPR/Cas9 KOプラスミド (h) | sc-402220 | h | Gene Knockout | GFP | 0 | ||
NCK1 HDRプラスミド (h) | sc-402220-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
NCK1 Double Nickaseプラスミド (h) | sc-402220-NIC | h | Gene Knockout | Puromycin | 0 | ||
NCK1 Double Nickaseプラスミド (h2) | sc-402220-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NCK1 CRISPR/Cas9 KOプラスミド (m) | sc-421833 | m | Gene Knockout | GFP | 0 | ||
NCK1 HDRプラスミド (m) | sc-421833-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NCK1 Double Nickaseプラスミド (m) | sc-421833-NIC | m | Gene Knockout | Puromycin | 0 | ||
NCK1 Double Nickaseプラスミド (m2) | sc-421833-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
NCK2 CRISPR/Cas9 KOプラスミド (h) | sc-403855 | h | Gene Knockout | GFP | 0 | ||
NCK2 HDRプラスミド (h) | sc-403855-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
NCK2 Double Nickaseプラスミド (h) | sc-403855-NIC | h | Gene Knockout | Puromycin | 0 | ||
NCK2 Double Nickaseプラスミド (h2) | sc-403855-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NCK2 CRISPR/Cas9 KOプラスミド (m) | sc-421834 | m | Gene Knockout | GFP | 0 | ||
NCK2 HDRプラスミド (m) | sc-421834-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NCK2 Double Nickaseプラスミド (m) | sc-421834-NIC | m | Gene Knockout | Puromycin | 0 | ||
NCK2 Double Nickaseプラスミド (m2) | sc-421834-NIC-2 | m | Gene Knockout | Puromycin | 0 |
NCK CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
NCK1 CRISPR Activationプラスミド (h) | sc-402220-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK1 CRISPR Activationプラスミド (h2) | sc-402220-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK1 Lentiviral Activation Particles (h) | sc-402220-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK1 Lentiviral Activation Particles (h2) | sc-402220-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK1 CRISPR Activationプラスミド (m) | sc-421833-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK1 CRISPR Activationプラスミド (m2) | sc-421833-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK1 Lentiviral Activation Particles (m) | sc-421833-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK1 Lentiviral Activation Particles (m2) | sc-421833-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK2 CRISPR Activationプラスミド (h) | sc-403855-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK2 CRISPR Activationプラスミド (h2) | sc-403855-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK2 Lentiviral Activation Particles (h) | sc-403855-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK2 Lentiviral Activation Particles (h2) | sc-403855-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK2 CRISPR Activationプラスミド (m) | sc-421834-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK2 CRISPR Activationプラスミド (m2) | sc-421834-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK2 Lentiviral Activation Particles (m) | sc-421834-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NCK2 Lentiviral Activation Particles (m2) | sc-421834-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |